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Abstract
Background: Intervertebral disc (IVD) disease is a common spinal disorder in dogs and degeneration and
inflammation are significant components of the pathological cascade. Only limited studies have studied the
cytokine and chemokine profiles in IVD degeneration in dogs, and mainly focused on gene expression. A better
understanding is needed in order to develop biological therapies that address both pain and degeneration in IVD
disease. Therefore, in this study, we determined the levels of prostaglandin E2 (PGE2), cytokines, chemokines, and
matrix components in IVDs from chondrodystrophic (CD) and non-chondrodystrophic (NCD) dogs with and without
clinical signs of IVD disease, and correlated these to degeneration grade (according to Pfirrmann), or herniation
type (according to Hansen). In addition, we investigated cyclooxygenase 2 (COX-2) expression and signs of
inflammation in histological IVD samples of CD and NCD dogs.
Results: PGE2 levels were significantly higher in the nucleus pulposus (NP) of degenerated IVDs compared with
non-degenerated IVDs, and in herniated IVDs from NCD dogs compared with non-herniated IVDs of NCD dogs.
COX-2 expression in the NP and annulus fibrosus (AF), and proliferation of fibroblasts and numbers of macrophages
in the AF significantly increased with increased degeneration grade. GAG content did not significantly change with
degeneration grade or herniation type. Cytokines interleukin (IL)-2, IL-6, IL-7, IL-8, IL-10, IL-15, IL-18, immune protein
(IP)-10, tumor necrosis factor (TNF)-α, and granulocyte macrophage colony-stimulating factor (GM-CSF) were not
detectable in the samples. Chemokine (C-C) motif ligand (CCL)2 levels in the NP from extruded samples were
significantly higher compared with the AF of these samples and the NP from protrusion samples.
Conclusions: PGE2 levels and CCL2 levels in degenerated and herniated IVDs were significantly higher compared
with non-degenerated and non-herniated IVDs. COX-2 expression in the NP and AF and reactive changes in the AF
increased with advancing degeneration stages. Although macrophages invaded the AF as degeneration progressed,
the production of inflammatory mediators seemed most pronounced in degenerated NP tissue. Future studies are
needed to investigate if inhibition of PGE2 levels in degenerated IVDs provides effective analgesia and exerts a
protective role in the process of IVD degeneration and the development of IVD disease.
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Background
Intervertebral disc (IVD) disease is a common spinal dis-
order in dogs and humans and is characterized by clin-
ical signs ranging from back pain to neurological
deficits. IVD disease is preceded by IVD degeneration
with a similar etiopathogenesis in dogs and humans [1].
Chondrodystrophic (CD) dogs are predisposed to explosive
extrusion of the nucleus pulposus (NP) (Hansen type I) of
degenerated thoracolumbar and cervical IVDs, mainly
between 3 and 7 years of age. Non-chondrodystrophic
(NCD) dogs are predisposed to protrusion of the annulus
fibrosus (AF) (Hansen type II) of degenerated lumbosacral
and caudal cervical IVDs at 6 to 8 years of age, and NP
extrusion of degenerated thoracolumbar IVDs [2–5].
Hansen type II annular protrusion does occur in CD dogs,
but less commonly [6, 7].
The onset of IVD degeneration at a cellular level is
characterized by a gradual replacement of notochordal
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cells by chondrocyte-like cells in the NP. In this respect,
the NP of CD dogs contains primarily chondrocyte-like
cells already by one year of age, while notochordal cells
remain the predominant cell type in the NP of NCD
dogs during their lifetime. In the latter, notochordal cells
in some IVDs are substituted and degeneration occurs at
a much later age [1, 8, 9]. In both types of dogs, a de-
crease in proteoglycan content, a shift in collagen type II
to collagen type I in the extracellular matrix of the NP,
together with a disruption of the lamellae in the annulus
fibrosus (AF) is seen during IVD degeneration [10, 11].
Furthermore, in degenerated discs, nerve endings extend
into the deeper layers of the AF and into the NP, in con-
trast to healthy discs, in which only the outer third of
the AF is innervated. Stimulation of nociceptors in the
AF and dorsal longitudinal ligament is related to pain
[12, 13]. A nociceptive response can either be evoked by
a mechanical or inflammatory stimulus. Various inflam-
matory mediators have also been suggested to play a role
in the catabolic processes in human NP and AF tissue,
including prostaglandin E2 (PGE2), interleukins (IL-1α,
IL-1β IL-6, IL-8), and tumor necrosis factor α (TNF-α)
[14–16]. In NP cells from experimental CD dogs with
surgically induced IVD degeneration increased levels of
TNF-α and IL-1β were shown in vitro [17]. While know-
ledge of the involvement of inflammatory mediators in
human IVD degeneration has substantially increased
over the last years [14–16, 18–34], only limited studies
have focused on cytokine and chemokine profiles in IVD
degeneration in dogs, and mainly focused on gene
expression [17, 35, 36].
PGE2 is the most common prostanoid and plays an
important regulatory role in physiological as well as
pathological processes. It is synthesized by two cyclooxy-
genase (COX) isoforms, COX-1 and COX-2, by conver-
sion of arachidonic acid into prostaglandin H2 (PGH2)
and isomerization of PGH2 to PGE2 by prostaglandin E
synthases. COX-2 expression is highly restricted under
physiological conditions, but can be rapidly induced in
response to inflammatory stimuli and is therefore be-
lieved to play an important role in the PGE2 production
involved in degenerative processes [27, 37]. Current ther-
apies of IVD disease aim at alleviating pain by administra-
tion of corticosteroids, non-steroidal anti-inflammatory
drugs (NSAIDs), and/or opioids, by physical therapy, or
by surgery. Among the numerous NSAIDs available, oral
selective COX-2 inhibitors are primarily used for
managing clinical signs, as they reduce inflammation and
relieve pain, but cause less gastrointestinal side effects
[38, 39]. Delivery of COX-2 inhibitors directly into the
avascular IVD has been suggested as an alternative route
of administration to enhance the local efficacy and to
minimalize systemic side effects. A recent study in experi-
mental CD dogs has shown the biocompatibility and
safety of intradiscal injection of a hydrogel loaded with a
selective COX-2 inhibitor [40]. As PGE2 is one of the
inflammatory mediators in human IVD herniation that
has been shown to sensitize nerves and induce pain, the
efficacy of intradiscal delivery of NSAIDs is likely to be
limited to IVD disease with a clear inflammatory profile
[41]. We hypothesize that PGE2 levels are higher in degen-
erated and herniated (protruded or extruded) IVDs of CD
and NCD dogs compared with non-degenerated or non-
herniated IVDs. Therefore, we determined the levels of
PGE2, cytokines, chemokines, and matrix components in
IVDs from CD and NCD dogs with and without clinical
signs of IVD disease and correlated these to degeneration
grade or herniation type. In addition, we investigated
COX-2 expression in histological IVD samples of CD and
NCD dogs.
Methods
Collection and preparation of samples for biochemical
analyses
IVDs collected post-mortem
A total of 19 IVDs, with a Thompson grade I and II, were
collected from 7 laboratory (3 CD, 4 NCD) dogs that were
euthanized in unrelated animal experiments (experiment
numbers: DEC 2007.III.08.110, DEC 2009.III.06.050),and a
total of 34 samples, with a Pfirrmann grade II, were col-
lected from 15 laboratory (CD) dogs from previous animal
experiments (DEC 2012.III.05.046, DEC 2013.III.02.017).
All animal experiments were approved by the Ethics
Committee of Animal Experiments (DEC) of Utrecht
University. None of the dogs had a history of clinical signs
of IVD disease. NP and AF tissues were isolated from the
spine and collected separately, snap frozen in liquid nitro-
gen, and stored at −80 °C until further analysis.
IVDs collected during surgical treatment
A total of 123 IVDs were collected from 76 client-owned
dogs that were referred to the University Clinic for
Companion Animals in Utrecht with IVD disease that
required surgical intervention. The diagnosis of IVD dis-
ease was confirmed on MRI or CT. Dogs were classified
as CD and NCD and divided into subgroups, based
on the Pfirrmann grade on T2-weighted MR images
[42, 43]. In 10 samples of 6 dogs, in which no MRI was
available, grading of the IVD was performed on CT im-
ages [43]. The medical history and records of the dogs
were screened for information on prior medical treatment
of IVD disease and the duration of this treatment.
Diagnostic imaging
Diagnostic imaging was performed in fully anesthetized
client-owned dogs, according to standard practice. MRI
images were obtained with a 0.2 Tesla open MRI system
(Magnetom Open Viva, Siemens AG, Erlangen, Germany)
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by using multipurpose flex coils until 2013, and thereafter
with a 1.5 Tesla scanner (Ingenia, Philips Healthcare, Best,
The Netherlands) by using a small-extremity or a poster-
ior coil. For each examination a coil was chosen that fitted
around the body of the patient as closely as possible.
Sagittal T2-weighted (T2W) images were acquired using a
turbo-spin echo pulse sequence with the following param-
eters: repetition time = 2500–3048 ms, echo time = 110–
120 ms, field of view = 50 x 160/160 x 350 mm, acquisi-
tion matrix = 100 x 256/200 x 235 mm, voxel size = 0.6 x
0.8/0.8 x 1.03 mm slice thickness = 2 – 2.5 mm. CT im-
ages were obtained with a third-generation single-slice
helical CT-scanner (Philips Secura). Contiguous 2 mm
thick slices with 1 mm overlap were obtained with expos-
ure settings of 120 kV and 260 mA.
Surgical treatment
Client-owned dogs were anesthetized according to
standard of care. Collection of IVDs was achieved
through standard surgical procedures, depending on the
location of disc herniation: ventral decompression in the
cervical area, dorsolateral hemilaminectomy in the
thoracolumbar area, and dorsal laminectomy in the lum-
bosacral area. In dogs with nuclear extrusion (Hansen
type I), free NP material was collected from the epidural
space in the spinal canal, and AF material was collected
during ventral fenestration preceding the ventral de-
compression for cervical disc herniations, or when an
additional lateral fenestration was performed after hemi-
laminectomy for thoracolumbar disc herniations. In dogs
with lumbosacral annular protrusion (Hansen type II),
partial discectomy consisting of annulotomy and nucleo-
tomy, allowed separate collection of NP and/or AF
tissue. In 3 dogs, an adjacent IVD was fenestrated, and
AF and/or NP material was collected. The treatment
decision (discectomy, nucleotomy, fenestration) was
taken during surgery and depended on the state of the
AF and the position of the NP. Each surgeon docu-
mented the type of herniation (NP extrusion (Hansen
type I) or AF protrusion (Hansen type II)) and type of
collected material (NP or AF) in the surgical report.
NP and/or AF tissues were collected in separate vials
during surgery, snap frozen into liquid nitrogen within mi-
nutes after collection, and subsequently stored at −80 °C
until further analysis. Details of the samples are shown in
Table 1 and in Additional file 1.
Biochemical analyses of IVDs collected post-mortem and
intra-operatively
Prior to analyses, samples were weighed, and 400 μl and
750 μl lysis buffer (cOmplete lysis M EDTA buffer, Roche
diagnostics Nederland B.V., Almere, The Netherlands)
was added to NP and AF tissue, respectively. Tissues were
lysed in a TissueLyser II (Qiagen, Venlo, The Netherlands)
for 2x 60 s at 20 kHz. After centrifugation for 15 min at
14.000 g, the volume of the supernatant of each sample was
measured and separated from its pellet. A volume of 80 μl
was filtered over a 0.22 μm nylon spin-X centrifuge tube
filter (8169, Costar, Corning Incorporated, NY, USA) and
stored at −80 °C in aliquots for cytokine measurements.
Glycosaminoglycan and DNA assays To determine
GAG and DNA, supernatants and pellets were digested
in a papain buffer (250 μg/ml papain (P3125-100 mg,
Sigma-Aldrich) + 1.57 mg cysteine HCL (C7880, Sigma-
Aldrich)) at 60 °C overnight. The 1.9-dimethylmethylene
blue (DMMB) assay was used to determine GAG con-
tent [44]. A volume of 16 mg DMMB (341088 Sigma-
Aldrich) was added to 5 ml 100 % ethanol and incubated
overnight on a roller bench. A solution of 2.37 g NaCl
and 3.04 g glycine in 1 l distilled water with a pH set at
3.00 was sterilized by using a 0.22 μm syringe filter
(SLGSV255F Millex-GS Syringe Filter Unit, Merck
Millipore, Darmstadt, Germany), added to the DMMB
solution, and stored at 4 °C, protected from light. Pellets
were diluted 1:1000 and supernatants 1:150 in PBS-
EDTA. A volume of 100 μl of the dilutions and stan-
dards was pipetted into a 96-wells microplate (655199
PS microplate, Greiner Bio-One, Alphen aan den Rijn,
Netherlands), and prior to spectrophotometric analysis,
200 μl of DMMB was added to each well. The ratio of
absorption at 540 to 595 nm was measured by using a
microplate reader (Multimode detector DTX 880,
Beckman Coulter). Chondroitin sulphate from shark car-
tilage (C4384, Sigma-Aldrich) was used as a standard to
calculate GAG concentrations. The Quant-iT™ dsDNA
Broad-Range assay kit in combination with a Qubit
Fluorometer (Invitrogen, Carlsbad, USA) was used ac-
cording to the manufacturer’s protocol to determine the
DNA content.
PGE2, and cytokine assays PGE2 levels were deter-
mined in the supernatants by using a colorimetric com-
petitive enzyme immunoassay kit (PGE2 high sensitivity
EIA kit, ENZO Life Sciences BVBA, Antwerp, Belgium).
A magnetic canine cytokine bead panel based on Luminex®
xMAP® technology (#CCYTOMAG-90 K/CCYTOMAG-
90 K-PX13); Milliplex® MAP kit, Millipore Corporation,
Billerica, USA) was used to measure twelve different
cytokines and chemokines in supernatants: TNF-α,
granulocyte-macrophage colony-stimulating factor (GM-
CSF), IL-2, IL-6, IL-7, IL-8, IL-10, IL-15, IL-18, chemokine
(C-C motif) ligand 2 (CCL2), chemokine (C-X-C motif)
ligand 1 (CXCL1), chemokine (C-X-C motif) ligand 10
(CXCL10). Supernatants were diluted 1:2 and were
measured according to the manufacturer’s instructions.
All biochemical values were corrected for weight of
the sample.
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Collection of post-mortem IVDs for histology
IVDs collected post-mortem
Post-mortem, 37 IVDs were collected from vertebral
columns of 16 client-owned dogs that were euthanized
for diseases other than IVD disease and submitted for
necropsy to the Department of Pathobiology at the
Faculty of Veterinary Medicine, Utrecht University, and
from 9 experimental dogs in unrelated cardiovascular
experiments (DEC 2007.II.01.029, DEC 2011.07.065).
Permission to collect material from the client-owned
dogs was granted by the owners. None of the dogs had a
reported history of back problems. Details of the dogs of
which material was collected for histology are shown in
Table 1.
Diagnostic imaging
Within 24 h after euthanasia or death, the vertebral
column (T11 – S1) was harvested by using an electric
multipurpose saw (Bosch, Stuttgart, Germany). Within
1 h after dissection, sagittal T2W MR images were ob-
tained with a 0.2 Tesla open MRI system (Magnetom
Open Viva, Siemens AG) as described earlier. All lumbar
IVDs were graded on midsagittal T2W images according
to the Pfirrmann score by two independent investigators
(NW, AT) [42].
Histology and immunohistochemistry
After scanning, all muscles were removed and the
vertebrae were transected transversely with a band saw
Table 1 Sample classification details
Samples biochemistry Samples histopathology
# Dogs CD dogs NCD dogs # Dogs CD dogs NCD dogs
58 40 15 10
Age – median 5 years 2 years Age – median (range(yrs)) 10 year 7 years
(range(mths – yrs)) (1–11 ) (8–12) (2–10) (1–10)
Spinal location NP AF NP AF Spinal location
# IVDs 35 30 36 41 # IVDs 19 18
Cervical (C1 – T1) 13 21 10 16 Cervical (C1 – T1) ND ND
Thoracolumbar (T1 – L1) 21 12 2 ND Thoracolumbar (T1 – L1) 5 8
Lumbar (L1 – S1) 11 7 23 25 Lumbar (L1 – S1) 14 10
Unknown 7 7 1 ND Unknown ND ND
Degeneration Degeneration
Grade 1 (non-surgical) ND ND 9a 10a Grade 1 2 8
Grade 2 32b 32c 9 9 Grade 2 4 7
Grade 3 7 6 8 8 Grade 3 3 3
Grade 4 + 5 13d 9d 10 12 + 2 Grade 4 + 5 3 + 3 3
Displacement Displacement
NP in situ (non-surgical) 27b,c 27b,c 9a 10a NP in situ ND
Nuclear extrusion 24 18 12 7 Nuclear extrusion ND
Annular protrusion 1 2 15 24 Annular protrusion ND
Treatment Treatment
No treatment 9 9 14 20 No treatment ND
Treatment 24 21 20 20
NSAID < 1 wk 7 8 7 4 NSAID < 1 wk ND
NSAID > 1 wk 6 7 8 9 NSAID > 1 wk ND
Steroids < 1 wk 4 2 1 ND Steroids < 1 wk ND
Steroids > 1 wk 4 3 2 2 Steroids > 1 wk ND
Other medication 3 1 2 5 Other medication ND
Unknown 2 ND 2 1 Unknown ND
aSamples collected from experimental dogs
b9 samples collected from experimental dogs (non-surgical); 17 samples collected in a previous study [40]
c4 samples collected from experimental dogs (non-surgical); 17 samples collected in a previous study [40]
d1 sample collected via fenestration
eSamples collected from experimental dogs;17 samples collected in a previous study [40]
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(EXAKT tape saw, EXAKT Advanced Technologies
GmbH, Norderstedt, Germany), resulting in spinal units
(endplate – IVD – endplate). These units were then
transected sagittally into two halves by using a diamond
band pathology saw (EXAKT 312 saw; EXAKT diamond
cutting band 0.1 mm D64; EXAKTAdvanced Technologies
GmbH, Norderstedt, Germany). Midsagittal slices (3 –
4 mm) were cut from one half and fixed in 4 % neutral
buffered formaldehyde and decalcified in EDTA. Samples
were dehydrated in graded alcohol series, rinsed in xylene,
and embedded in paraffin. Sections (5 μm) were cut,
deparaffinized and rehydrated, and stained with both
hematoxylin (109249, Merck)/eosin (115935, Merck), and
with picrosirius red (saturated aqueous picric acid: 36011,
Sigma-Aldrich, sirius red: 8015, Klinipath)/alcian blue
(alcian blue: 05500, Sigma-Aldrich; glacial acetic acid:
100063, Merck). Histological sections were assessed for
the presence of inflammatory cells, and evaluated ac-
cording to a histological grading scheme described by
Bergknut et al. [45].
Immunohistochemistry for COX-2 was performed on
5 μm sections mounted on KP plus glass slides
(Klinipath B.V., Duiven, The Netherlands). After deparaffi-
nization and rehydration sections were treated with Dual
Endogenous Enzyme Block (S2003, Dako, California,
USA) for 10 min at room temperature to block nonspe-
cific endogenous peroxidase, followed by 2 washing steps
of each 5 min with tris buffered saline containing 1 %
Tween 20® (TBS-T). Sections were treated with TBS
bovine serum albumin (BSA) 5 % solution to block non-
specific binding for 60 min at room temperature.
Subsequently they were incubated with a primary mouse
anti-human monoclonal COX-2 antibody (#160112 Clone
CX229, Cayman, Ann Arbor, USA) diluted 1:800 in TBS-
BSA 5 % overnight at 4 °C. The following day sections
were incubated with peroxidase-labelled polymer (K4007;
Envision anti-mouse, Dako) and antibody binding was
visualized by using diaminobenzidine (DAB; K4007;
Dako). Sections were counterstained with hematoxylin
solution (Hematoxylin QS, Vector, Peterborough, UK),
rehydrated and mounted in permanent mounting medium.
The percentage of COX-2 positive chondrocytes in the NP,
and in the dorsal AF (DAF) was determined by manual
counting by a blinded independent investigator (AT).
Statistical analyses
Data were analyzed by using R statistical software, pack-
age 2.15.2 (http://www.r-project.org/). A multiple linear
regression model was used to analyze the effect of mul-
tiple explanatory variables on corrected PGE2, GAG, and
DNA levels for the wet weight of the tissues. Further-
more, in order to be able to compare this study with
previous reports [40], PGE2 levels were also corrected
for DNA content. Data were logarithmically transformed
to achieve normality. Two separate models were
employed to investigate the association of explanatory
variables ‘grade’ (Pfirrmann grade I – IV) and ‘herniation’
(NP in situ, NP extrusion, AF protrusion) with inflamma-
tory parameters. Variables incorporated into both models
were ‘dog’ (CD, NCD), ‘tissue’ (NP and AF), ‘treatment’
(no treatment, NSAID administered less than (<) 1 wk,
NSAID administered more than (>) 1 wk, corticosteroids
(cort) < 1 wk, cort > 1 wk, other) and their interaction. Re-
sidual plots and quantile-quantile (QQ)-plots were used
to check the critical assumptions of linearity, equal vari-
ance at all fitted values and the assumption of normally
distributed residuals. The Cox proportional hazards re-
gression model was used for analysis of the COX-2 values,
that did not approximate a normal distribution after log
transformation. ‘Grade’ (Pfirrmann grade I – IV) and
‘breed’ (CD, NCD) and their interaction were incorporated
into this model. Calculations were performed on values
distracted from 100 %. In the absence of COX-2 positive
cells the sample was set at 100 % and right censored.
Histological reactive changes in the IVDs were statistically
evaluated by using the nonparametric Kruskal-Wallis test,
followed by a Mann–Whitney U-test. The Spearman’s cor-
relation coefficient was calculated to estimate the correl-
ation between the presence of inflammatory cells (‘yes’ or
‘no’) and COX-2 positive cells.
For all statistical models, regression coefficients were
estimated by the maximum likelihood method. Model
selection was based on the lowest Akaike Information
Criterion (AIC). Confidence intervals were calculated
and stated at the 99 % confidence level to correct for
multiple comparisons. Differences between treatments
were considered significant if the confidence interval did
not include 0, whereas hazard ratios were considered
significant if the confidence interval did not include 1.
Significant differences and the corresponding confidence
intervals are represented in Additional file 2.
Results
Extracellular matrix components and inflammatory
profiles in relation to stage of degeneration
GAG content normalized for wet weight did not signifi-
cantly change with degeneration grade according to
Pfirrmann (Fig. 1a and b). In grade IV + V samples the
GAG content in the NP was significantly lower than in
the AF (Fig. 1a). DNA expressed as μg/mg wet weight
was significantly lower in grade II samples compared
with grade IV + V samples (Fig. 1b). Due to sample limi-
tations, samples that were above the upper range of the
PGE2 assay (>1000 pg/ml) were set at 1000 pg/ml. PGE2
levels normalized for wet weight were significantly lower
in grade I NP samples compared with those in grade II,
III, and IV + V NP samples (Fig. 2a). PGE2 levels normal-
ized for DNA were significantly lower in grade I samples
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compared with grade II, III, and IV + V samples regard-
less of the tissue origin (NP/AF), dog type (CD/NCD),
or treatment group (no treatment, NSAID < 1 wk,
NSAID > 1 wk, cort < 1 wk, cort > 1 wk, other) (Fig. 2b).
Cytokines IL-2, IL-6, IL-7, IL-8, IL-10, IL-15, IL-18,
IP-10, TNF-α, and GM-CSF were not detectable in the
samples. Chemokine CCL2 was measured in 66/120 sam-
ples and chemokine CXCL1 in 119/120 samples. CXCL1
and CCL2 expressed as pg/gram wet weight did not sig-
nificantly change with degeneration (Fig. 2c and d). There
were no significant differences between treatment groups.
Extracellular matrix components and inflammatory
profiles in relation to herniation of NP and AF
GAG and DNA (Fig. 1c and d) and CXCL1 (Fig. 2d
and e) expressed as pg/gram wet weight were not signifi-
cantly different between herniation groups. PGE2 levels
normalized for either DNA content or wet weight, were
significantly lower in non-herniated samples compared
with extruded and protruded samples of NCD dogs, re-
gardless of the tissue origin (NP/AF), or treatment group
(no treatment, NSAID < 1 wk, NSAID > 1 wk, cort < 1 wk,
cort > 1 wk, other). CCL2 levels in the NP from extruded
samples were significantly higher compared with the AF
of these samples and the NP from protrusion samples
regardless of the dog breed (CD/NCD) (Fig. 2f). There
were no significant differences between biochemical pa-
rameters of CD and NCD dogs or treatment groups.
Pfirrmann grade II samples from this study were com-
pared with Pfirrmann grade II samples obtained from
experimental CD dogs (Fig. 3a) [40]. As sample weights
were not available in the previous study, PGE2 was nor-
malized for DNA. In this combined Pfirrmann grade II
dataset, PGE2/DNA in the NP was significantly higher in
extruded samples compared with Pfirrmann grade II
IVDs with the NP in situ. To compare this combined
Pfirrmann grade II dataset to the complete dataset, we
have normalized PGE2 for DNA (Fig. 3b and c).
Histology and COX-2 expression
Histological scores according to the grading scheme by
Bergknut et al. ranged from 7 – 12 (median = 8) for
Pfirrmann grade1, 8 – 27 (median = 14) for Pfirrmann
grade II, 14 – 20 (median =19) for Pfirrmann grade III,
and 18 – 26 (median = 21) for Pfirrmann grade IV + V.
In 5/37 IVDs from 3/16 dogs ventral bone formation
was seen in grade I – V IVDs. Histology revealed no in-
flammatory cells or fibroblasts in the NP of Pfirrmann
grade I – V IVDs, and in the dorsal AF of Pfirrmann
grade I IVDs. However, in higher degeneration grades,
Fig. 1 Mean + standard deviation GAG and DNA content normalized for weight in the nucleus pulposus (NP) and annulus fibrosus (AF) per
Pfirrmann grade (a, b) and per herniation (c, d). a. GAG/weight levels were significantly higher in the AF compared with the NP in grade IV + V
samples. b. DNA/weight was significantly lower in the NP of grade II samples compared with grade IV + V. c and d. Normalized GAG and DNA
levels did not significantly differ between herniation groups. No significant differences were shown between dog (CD/NCD) or treatment (no
treatment, NSAID < 1 wk, NSAID > 1 wk, corticosteroids (cort) < 1 wk, cort > 1 wk, other) groups, hence these groups are not shown separately.
** Indicate significant difference at a 99 % confidence level
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focal infiltration of macrophages, proliferation of fibro-
blasts and capillaries were detected in the dorsal and/or
the ventral ligament, extending into the outer layers of
the dorsal and ventral AF, respectively (Fig. 3). Macro-
phages and proliferation of fibroblasts were present in
0 % (0/10), 10 % (1/10), 83 % (5/6) and 55 % (6/11) of
the IVDs scored a Pfirrmann grade I, II, III, IV + V, re-
spectively. Numbers of macrophages and fibroblasts in
grade IV + V IVDs were significantly higher than in
grade I, and in grade III significantly higher than in
grade I and II. Protrusion of the AF was seen in a grade
II and a grade IV + V IVD.
Percentages of COX-2-positive cells in the NP and
dorsal AF of grade I and grade II tissue were signifi-
cantly lower compared with the NP and dorsal AF of
grade IV + V samples (Fig. 4 and Fig. 5). The presence of
macrophages and fibroblasts in the dorsal AF was mod-
erately correlated (Spearman’s ρ = 0.4, p-value = 0.003)
with COX-2 positive cells in the dorsal AF.
Discussion
To our knowledge this is the first study that describes
levels of COX-2, PGE2, cytokines, chemokines, and
matrix components in IVDs from CD and NCD dogs
with and without clinical signs of IVD disease and de-
generation. PGE2 levels were significantly higher in
degenerated IVDs compared with non-degenerated
IVDs, and they were also higher in herniated (protruded
and extruded) IVDs from NCD dogs compared with
non-herniated IVDs of NCD dogs. In contrast to PGE2
Fig. 2 Mean + standard deviation PGE2 and chemokine (CCL2 and CXCL1) levels normalized for weight in the nucleus pulposus (NP) and annulus
fibrosus (AF) per Pfirrmann grade (a, b, c) and per herniation (d, e, f). a. PGE2 levels expressed as pg/mg wet weight in grade I NP samples were
significantly lower compared with grade II, III, and IV + V NP samples. c, b and c. CCL2 and CXCL1 levels normalized for weight did not significantly
change with degeneration. d. PGE2 levels did not significantly differ in the NP and AF between the three herniation groups. e. CXCL1 levels did not
significantly differ between herniation groups. f. CCL2 levels normalized for weight in the NP from extruded samples were significantly higher
compared with the AF of these samples and the NP from protruded samples. No significant differences were shown between treatment
(no treatment, NSAID < 1 wk, NSAID > 1 wk, corticosteroids (cort) < 1 wk, cort > 1 wk, other) groups, hence these groups are not shown
separately. ** Indicate significant difference at a 99 % confidence level
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Fig. 3 Mean + standard deviation PGE2 levels normalized for DNA
content in the nucleus pulposus (NP) and annulus fibrosus (AF)
in Pfirrmann grade II samples obtained from experimental
chondrodystrophic (CD) dogs (a), and in the complete dataset
(CD and nonchondrodystrophic (NCD) dogs) per Pfirrmann grade
(b), and per herniation (c). a. PGE2 levels expressed as pg/μg
DNA in the NP of CD dogs were significantly higher in extruded
grade II samples compared with NP in situ samples. b. PGE2 levels
normalized for DNA were significantly lower in grade I samples
compared with grade II, III, and IV + V samples regardless of the
tissue origin (NP/AF), dog group (CD/NCD), or treatment group
(no treatment, NSAID < 1 wk, NSAID > 1 wk, corticosteroids (cort) < 1 wk,
cort > 1 wk, other). c. PGE2 levels expressed as pg/μg DNA were
significantly lower in non-herniated samples compared with extruded
and protruded samples in NCD dogs, regardless of the tissue origin
(NP/AF), or treatment group (no treatment, NSAID < 1 wk, NSAID > 1
wk, corticosteroids (cort) < 1 wk, cort > 1 wk, other). ** Indicate
significant difference at a 99 % confidence level
Fig. 4 Representative histological images of the annulus fibrosus (AF)
of intervertebral discs (IVDs) graded according to Pfirrmann stained
with a COX-2 antibody and counterstained with hematoxylin. a. The
dorsal AF of a non-degenerated Pfirrmann grade 1 IVD consisted
of well-organized lamellae with COX-2 negative spindle-shaped
fibroblasts (asterisks). b. In the dorsal AF of a degenerated Pfirrmann
grade IV IVD lamellar organization was lost and COX-2 negative
chondrocytes (arrowheads) as well as COX-2 positive chondrocytes
(arrows) were present. c. The dorsal AF of a Pfirrmann grade V IVD
consisted of COX-2 negative chondrocytes (arrowheads), whereas
COX-2 positive macrophages (open arrows) were situated in the
dorsal ligament
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levels in Pfirrmann grade II IVDs from CD dogs with
(a limited number of ) protruded IVDs, PGE2 levels in
extruded IVDs were not significantly different from IVDs
with the NP in situ. Furthermore, COX-2 protein expres-
sion was significantly higher in degenerated IVDs com-
pared with non-degenerated IVDs. These results are
consistent with findings in herniated human lumbar IVD
cells that produced increased PGE2 levels spontan-
eously in vitro compared with PGE2 levels in control
IVD cells [15].
Contrary to PGE2 levels, COX-2 expression in the NP
and AF and numbers of macrophages in the dorsal and
ventral ligaments were increased in advanced stages of
degeneration. Histological results of non-herniated
degenerated IVDs in our study are consistent with histo-
logical findings described in studies on canine herniated
IVDs. In extruded IVDs an acute inflammatory reaction
has been described, characterized by neutrophils and
macrophages, while in protruded IVDs a more chronic
inflammatory reaction has been described, characterized
by macrophages, lymphocytes and plasma cells [46, 47].
Macrophages do not only have a phagocytic function,
but secret next to cytokines also a number of growth
factors, e.g. fibroblast growth factor, transforming
growth factor beta, that can induce neovascularization
and mediate cell proliferation and differentiation [48].
The focal infiltrates of macrophages, proliferation of
fibroblasts and capillaries, and the new bone formation
as was seen histologically in some IVDs are reactive tis-
sue changes that might reflect a process of tissue repair.
Although a physiological inflammatory response to asep-
tic tissue injury primarily serves to promote tissue repair,
macroscopic findings may reflect an excessive inflam-
matory response. This response may have detrimental
effects on tissue integrity, and may contribute to the
pathogenesis of IVD degeneration and/or disease.
Significantly higher PGE2 levels in degenerated NP
tissues compared with non-degenerated IVDs were
observed. Although not significantly different, PGE2
levels and COX-2 expression in grade II and IV + V
IVDs were consistently higher in the NP of degenerated
IVDs compared with AF, while the contrary was true for
non-degenerated IVDs. In Pfirrmann grade II samples
from CD dogs, PGE2 levels in the NP were significantly
higher in Pfirrmann grade II IVDs with protrusion com-
pared with IVDs with the NP in situ. This may indicate
that the production of inflammatory mediators is more
pronounced at the NP level. We cannot exclude that NP
and AF cells respond differently to inflammatory stimuli
and mechanic stress and hence produce different levels
of PGE2, as also suggested by others based on in vitro
experiments in rat IVD cells [49]. Cytokine and chemo-
kine profiles in this study are largely consistent with lim-
ited veterinary publications. The significantly increased
CCL2 levels in NP tissue of dogs with Hansen type I
herniation compared with AF tissue and NP tissue in
dogs with Hansen type II herniation are in line with
other studies reporting upregulated gene expression
levels of CCL2 in dogs with extrusion of the NP [35].
Furthermore, increased CCL2 protein expression and
CCL2 production levels have been reported in human
prolapsed IVDs [28]. No studies in canine tissues, and
only limited studies in human tissues, have determined
cytokine and/or chemokine levels by using a (multiplex)
sandwich immunoassay, and have shown increased levels
of IFN-γ, IL-1, TNF-α, and CCL2, in epidural lavage
fluid and in cell culture media, which complicates
comparison of results [51–53]. Cytokine levels of IL-2,
IL-6, IL-7, IL-8, IL-10, IL-15, IL-18, IP-10, TNF-α, and
GM-CSF were not detected in NP and AF tissues of this
study, consistent with downregulated gene expression
levels of IL-2, IL-6, IL-10, and TNF-α in herniated
canine IVDs [35]. Nevertheless, our findings seem to be in
contrast with increased protein and gene expression levels
of TNF-α and IL-1 in human IVDs [23–25, 28, 29, 54].
Given the short half-life of TNF- α and cytokines [55, 56],
and that all samples collected from degenerated IVDs
were obtained during surgery and in several cases after
flushing of the spinal canal, we cannot rule out degrad-
ation of cytokines/chemokines by the collection, prepar-
ation, and storage process. Although several studies have
shown that IVD cells have the capacity to produce PGE2,
we cannot rule out that PGE2 levels were influenced by
infiltration from the epidural space.
Despite elevated PGE2 levels in degenerated NP tissue
in this study, GAG content was not significantly dif-
ferent between healthy and degenerated IVDs, while
severely degenerated AFs (grade IV +V) had a higher GAG
content compared with the NP. The latter may be ex-
plained by the presence of GAG-producing chondrocytes
Fig. 5 Percentage of COX-2-positive cells in the nucleus pulposus
(NP) and annulus fibrosus (AF) per Pfirrmann grade. The NP and AF
of grade I and grade II samples were significantly lower compared
with the NP and AF grade IV + V samples. ** Indicate significant
difference at a 99 % confidence level
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in the AF, known to be present in later stages of degener-
ation [45], or by the presence of unidentified GAG-rich
herniated NP and/or inner AF material in AF samples.
These findings are in contrast with the decrease in GAG
content with increasing IVD degeneration described in
literature [1, 11]. One plausible explanation for this
discrepancy lies in the scoring system of degeneration
prior to surgery and the matrix heterogeneity of the
degenerated NP tissue, discussed in detail below. Interest-
ingly, cell density (DNA/weight) in our study was signifi-
cantly higher in the NP of severely degenerated IVDs
compared with mildly degenerated IVDs. These findings
touch upon findings in human IVD degeneration, in
which cell density in the inner AF and NP of severely
degenerated (Thompson grade V) specimens was signifi-
cantly higher compared with lower grades [57, 58].
The results on the effects of PGE2 on proteoglycan
metabolism are conflicting.PGE2 at concentrations much
lower than those involved in inflammation have been
demonstrated to be chondroprotective [59]. PGE2 has
been described to have anti-catabolic effects by down-
regulating the expression and synthesis of IL-1, TNF- α,
and matrix metalloproteinases (MMPs), and to have ana-
bolic effects by to inducing the expression, synthesis and
secretion of IGF-I, and stimulating collagen and proteo-
glycan synthesis, important factors in anabolic processes
[16, 60–62]. In vitro, low concentrations of PGE2 have
been described to stimulate proteoglycan synthesis in rat
chondrocytes, whereas higher doses have been described
to decrease proteoglycan synthesis in NP cells [16, 61].
Furthermore, degradation of proteoglycans was not
inhibited by a range of PGE2 concentrations in osteo-
arthritic chondrocytes [60]. These possible protective
effects of PGE2 might have resulted in preservation of
GAG content in the course of IVD degeneration. Never-
theless, these results should be interpreted with care, as
GAG content of the studied tissues may have been
affected by confounding factors explained below.
There are several confounding factors that may affect
the results in the current study, including the factors
that influence the scoring system of degeneration and
the matrix heterogeneity of the degenerated NP tissue.
Extruded NP tissue displaced into the vertebral canal
results in narrowing of the disc space and a T2-
hypointense area within the IVD on MRI. Hence, we
cannot exclude that prior to the extrusion incident the
IVD may have been assessed with a lower Pfirrmann
score. Moreover, in CD dogs, calcification of the NP
could have negatively influenced the signal intensity in
the NP [63, 64]. In addition, in both CD and NCD dogs,
IVDs may have been graded falsely higher due to
hemorrhage or inflammation, that may have influenced
the appearance of the IVD on MR images. Matrix het-
erogeneity is common in degenerating NP tissue. In
human IVDs several disc-specific locations are described
with a high variation in GAG and water content, sug-
gestive of focal damage and degeneration [65]. Although
this has not yet been described in dogs, we cannot rule
out that tissues collected during surgery may have
originated from specific GAG-rich areas in the IVD, that
inherently are more prone to extrusion/protrusion com-
pared with degenerated fibrotic tissue. Furthermore, due
to sample limitations PGE2 values higher than 1000 pg/ml
could not be measured reliably, but could have resulted in
an underestimation of the highest samples. Lastly, a
relatively high percentage of dogs in this study was
treated prior to surgery with anti-inflammatory drugs,
e.g. NSAIDs and corticosteroids. Dogs that did not re-
spond to anti-inflammatory drugs initially, were treated
with other drugs, e.g. opioids, GABA-agonists. Although
treatment groups were categorized, duration of treatment
and dosages used showed a high variation, and might have
had an influence on the results.
From a clinical perspective, decompression surgery is
recommended if dogs present with clinical signs, and
diagnostic work-up indicates compression of neural
tissue (spinal cord and/or nerve roots) due to extruded
material. With regard to an intradiscal application that
provides controlled release of an anti-inflammatory
drug, future studies should focus on protruded IVDs.
Obviously, this would indicate development of an appli-
cation in NCD dogs, as disc protrusion rarely occurs in
CD dogs. IVDs ideally should be early degenerated
(Pfirrmann grade II – III), without irreversible anatom-
ical malformations due to degenerative changes.
Conclusion
In this study we have shown that PGE2 levels, and CCL2
levels in degenerated and herniated tissues were signifi-
cantly higher compared with non-degenerated and non-
herniated tissues. COX-2 expression in the NP and AF
and numbers of macrophages in the AF increased with
advancing degeneration stages. Although macrophages
invade the dorsal and ventral AF as degeneration
progresses, the production of inflammatory mediators
seems most pronounced in degenerated NP tissue.
Future studies are needed to investigate if inhibition of
PGE2 levels in degenerated IVDs provide effective
analgesia and exerts a protective role in the process
of IVD degeneration and the development of IVD
disease.
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